Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation

Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to‐head comparisons

(2019) Taishiro Kishimoto et al.   World Psychiatry

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

(2019) Maximilian Huhn et al.   LANCET

What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

(2018) Christoph U. Correll et al.   World Psychiatry

Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies

(2017) Taishiro Kishimoto et al.   SCHIZOPHRENIA BULLETIN

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1)

(2016) Jordi Llaudó et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

(2016) Christoph U. Correll et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia

(2016) Azmi F. Nasser et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Population pharmacokinetic modeling and simulations of long-acting intramuscular risperidone ISM®

(2015) J. Winkler et al.   CLINICAL THERAPEUTICS

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

(2015) Herbert Y. Meltzer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Schizophrenia

(2015) René S. Kahn et al.   Nature Reviews Disease Primers

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia

(2014) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry

(2013) John M. Kane et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia

(2013) Taishiro Kishimoto et al.   JOURNAL OF CLINICAL PSYCHIATRY

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

(2013) John M. Kane et al.   World Psychiatry

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

(2011) T Kishimoto et al.   MOLECULAR PSYCHIATRY

A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia

(2010) Gahan J. Pandina et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY